{"id":452460,"date":"2021-03-08T08:03:21","date_gmt":"2021-03-08T13:03:21","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=452460"},"modified":"2021-03-08T08:03:21","modified_gmt":"2021-03-08T13:03:21","slug":"dare-bioscience-to-participate-at-the-33rd-annual-roth-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/","title":{"rendered":"Dar\u00e9 Bioscience to Participate at the 33rd Annual Roth Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, March  08, 2021  (GLOBE NEWSWIRE) &#8212; Dar\u00e9\u00a0Bioscience, Inc. (NASDAQ: DARE), a leader in women\u2019s health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will participate in a panel discussion titled \u201cWomen\u2019s Health Companies Blazing the Trail\u201d at the 33<sup>rd<\/sup> Annual Roth Conference that will take place virtually March 15 \u2013 17, 2021.<\/p>\n<p align=\"justify\">A webcast of the panel discussion will be available beginning March 15, 2021 at 5:00pm Eastern Time under \u201cPresentations, Events &amp; Webcasts&#8221; in the Investors section of the company&#8217;s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=p331jzDZwqTMqemU2jQik74AcsKIJc_UeSD2UPHA4EbOO7UUpGkqocoEDYHdTr326jd8KIcaSv0ZINzGoClzui--yp-ijOygtSoNNuqOVMY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/ir.darebioscience.com<\/a>. The webcast will be available until March 29, 2021.<\/p>\n<p align=\"justify\">\n        <strong>About Dar\u00e9 Bioscience<\/strong>\n      <\/p>\n<p align=\"justify\">Dar\u00e9 Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women\u2019s health. The company\u2019s mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health, and fertility.<\/p>\n<p align=\"justify\">Dar\u00e9\u2019s product portfolio includes potential first-in-category candidates in clinical development: Ovaprene\u00ae, a hormone-free, monthly contraceptive intravaginal ring whose\u00a0U.S.\u00a0commercial rights are under a license agreement with Bayer; Sildenafil Cream, 3.6%, a novel cream formulation of sildenafil to treat female sexual arousal disorder utilizing the active ingredient in Viagra\u00ae; DARE-BV1, a unique hydrogel formulation of clindamycin phosphate 2% to treat bacterial vaginosis via a single application; and DARE-HRT1, a combination bio-identical estradiol and progesterone intravaginal ring for hormone replacement therapy following menopause. To learn more about Dar\u00e9\u2019s full portfolio of women\u2019s health product candidates, and mission to deliver differentiated therapies for women, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Yb-W13CVvakEIUcK8Aw1I6a2SFluzlnGwMr8B-QJY8Nm57o_KJ_hn1CujoB6M_dJfawt3llUKBAIk2D6NDlkbq0oIRXUx4THVeGEP4tGCcU=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.darebioscience.com<\/a>.<\/p>\n<p align=\"justify\">Dar\u00e9 may announce material information about its finances, product candidates, clinical trials and other matters using the Investors section of its website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=p331jzDZwqTMqemU2jQik74AcsKIJc_UeSD2UPHA4EbzrXT0wsjGeYrXTEXrpwiSIyYZm59IuBeIQtESQAdYO8Skdx52yYq2oDQGiZKfLZ4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/ir.darebioscience.com<\/a>),\u00a0SEC\u00a0filings, press releases, public conference calls and webcasts. Dar\u00e9 will use these channels to distribute material information about the company, and may also use social media to communicate important information about the company, its finances, product candidates, clinical trials and other matters. The information Dar\u00e9 posts on its investor relations website or through social media channels may be deemed to be material information. Dar\u00e9 encourages investors, the media, and others interested in the company to review the information Dar\u00e9 posts in the Investors section of its website and to follow these Twitter accounts: @SabrinaDareCEO and @DareBioscience. Any updates to the list of social media channels the company may use to communicate information will be posted on the investor relations page of Dar\u00e9\u2019s website mentioned above.<\/p>\n<p align=\"justify\">\n        <strong>Contact:<\/strong>\n      <\/p>\n<p align=\"justify\">Investors on behalf of Dar\u00e9 Bioscience, Inc.:<br \/>Tom Masterson<br \/>Allele Capital Partners<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XtrlhoLwOwMtbFL0-znpvQGb4G-161JjtpVC055tfc8xzP2peZDnsG7vVu_-Oqbbhjb_uotuoqXvPcR-RRSY58mJadyeea6bVlqERKEJgOqqUHypCVBB_m1_a4oEbzfq\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">tmasterson@allelecapital.com<\/a><br \/>646.573.3216<\/p>\n<p align=\"justify\">Source: Dar\u00e9 Bioscience, Inc.<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTQzNCM0MDUxMTA5IzIwMDgzNjQ=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/0aed8445-2d40-4a0b-ae18-6aac9e403e26\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, March 08, 2021 (GLOBE NEWSWIRE) &#8212; Dar\u00e9\u00a0Bioscience, Inc. (NASDAQ: DARE), a leader in women\u2019s health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will participate in a panel discussion titled \u201cWomen\u2019s Health Companies Blazing the Trail\u201d at the 33rd Annual Roth Conference that will take place virtually March 15 \u2013 17, 2021. A webcast of the panel discussion will be available beginning March 15, 2021 at 5:00pm Eastern Time under \u201cPresentations, Events &amp; Webcasts&#8221; in the Investors section of the company&#8217;s website at\u00a0http:\/\/ir.darebioscience.com. The webcast will be available until March 29, 2021. About Dar\u00e9 Bioscience Dar\u00e9 Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women\u2019s health. The &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Dar\u00e9 Bioscience to Participate at the 33rd Annual Roth Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-452460","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dar\u00e9 Bioscience to Participate at the 33rd Annual Roth Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dar\u00e9 Bioscience to Participate at the 33rd Annual Roth Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, March 08, 2021 (GLOBE NEWSWIRE) &#8212; Dar\u00e9\u00a0Bioscience, Inc. (NASDAQ: DARE), a leader in women\u2019s health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will participate in a panel discussion titled \u201cWomen\u2019s Health Companies Blazing the Trail\u201d at the 33rd Annual Roth Conference that will take place virtually March 15 \u2013 17, 2021. A webcast of the panel discussion will be available beginning March 15, 2021 at 5:00pm Eastern Time under \u201cPresentations, Events &amp; Webcasts&#8221; in the Investors section of the company&#8217;s website at\u00a0http:\/\/ir.darebioscience.com. The webcast will be available until March 29, 2021. About Dar\u00e9 Bioscience Dar\u00e9 Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women\u2019s health. The &hellip; Continue reading &quot;Dar\u00e9 Bioscience to Participate at the 33rd Annual Roth Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-08T13:03:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTQzNCM0MDUxMTA5IzIwMDgzNjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dar\u00e9 Bioscience to Participate at the 33rd Annual Roth Conference\",\"datePublished\":\"2021-03-08T13:03:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\\\/\"},\"wordCount\":449,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTQzNCM0MDUxMTA5IzIwMDgzNjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\\\/\",\"name\":\"Dar\u00e9 Bioscience to Participate at the 33rd Annual Roth Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTQzNCM0MDUxMTA5IzIwMDgzNjQ=\",\"datePublished\":\"2021-03-08T13:03:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTQzNCM0MDUxMTA5IzIwMDgzNjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTQzNCM0MDUxMTA5IzIwMDgzNjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dar\u00e9 Bioscience to Participate at the 33rd Annual Roth Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dar\u00e9 Bioscience to Participate at the 33rd Annual Roth Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/","og_locale":"en_US","og_type":"article","og_title":"Dar\u00e9 Bioscience to Participate at the 33rd Annual Roth Conference - Market Newsdesk","og_description":"SAN DIEGO, March 08, 2021 (GLOBE NEWSWIRE) &#8212; Dar\u00e9\u00a0Bioscience, Inc. (NASDAQ: DARE), a leader in women\u2019s health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will participate in a panel discussion titled \u201cWomen\u2019s Health Companies Blazing the Trail\u201d at the 33rd Annual Roth Conference that will take place virtually March 15 \u2013 17, 2021. A webcast of the panel discussion will be available beginning March 15, 2021 at 5:00pm Eastern Time under \u201cPresentations, Events &amp; Webcasts&#8221; in the Investors section of the company&#8217;s website at\u00a0http:\/\/ir.darebioscience.com. The webcast will be available until March 29, 2021. About Dar\u00e9 Bioscience Dar\u00e9 Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women\u2019s health. The &hellip; Continue reading \"Dar\u00e9 Bioscience to Participate at the 33rd Annual Roth Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-08T13:03:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTQzNCM0MDUxMTA5IzIwMDgzNjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dar\u00e9 Bioscience to Participate at the 33rd Annual Roth Conference","datePublished":"2021-03-08T13:03:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/"},"wordCount":449,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTQzNCM0MDUxMTA5IzIwMDgzNjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/","name":"Dar\u00e9 Bioscience to Participate at the 33rd Annual Roth Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTQzNCM0MDUxMTA5IzIwMDgzNjQ=","datePublished":"2021-03-08T13:03:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTQzNCM0MDUxMTA5IzIwMDgzNjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTQzNCM0MDUxMTA5IzIwMDgzNjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dare-bioscience-to-participate-at-the-33rd-annual-roth-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dar\u00e9 Bioscience to Participate at the 33rd Annual Roth Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/452460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=452460"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/452460\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=452460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=452460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=452460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}